Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

March 29, 2022; 98 (13) Resident & Fellow Section

Clinical Reasoning: A Dizzy Architect

Adrian Scutelnic, Aikaterini Galimanis, View ORCID ProfileMichael Horn, Lidia Sabater, Niklaus Meier
First published February 4, 2022, DOI: https://doi.org/10.1212/WNL.0000000000200019
Adrian Scutelnic
From the Department of Neurology (A.S., A.G., N.M.), Thun Hospital; Center of Laboratory Medicine (M.H.), University Institute of Clinical Chemistry, University Hospital, Inselspital, Bern, Switzerland; and Neurology Service (L.S.), Hospital Clinic de Barcelona and Institut d'Investigació Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aikaterini Galimanis
From the Department of Neurology (A.S., A.G., N.M.), Thun Hospital; Center of Laboratory Medicine (M.H.), University Institute of Clinical Chemistry, University Hospital, Inselspital, Bern, Switzerland; and Neurology Service (L.S.), Hospital Clinic de Barcelona and Institut d'Investigació Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Horn
From the Department of Neurology (A.S., A.G., N.M.), Thun Hospital; Center of Laboratory Medicine (M.H.), University Institute of Clinical Chemistry, University Hospital, Inselspital, Bern, Switzerland; and Neurology Service (L.S.), Hospital Clinic de Barcelona and Institut d'Investigació Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Horn
Lidia Sabater
From the Department of Neurology (A.S., A.G., N.M.), Thun Hospital; Center of Laboratory Medicine (M.H.), University Institute of Clinical Chemistry, University Hospital, Inselspital, Bern, Switzerland; and Neurology Service (L.S.), Hospital Clinic de Barcelona and Institut d'Investigació Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niklaus Meier
From the Department of Neurology (A.S., A.G., N.M.), Thun Hospital; Center of Laboratory Medicine (M.H.), University Institute of Clinical Chemistry, University Hospital, Inselspital, Bern, Switzerland; and Neurology Service (L.S.), Hospital Clinic de Barcelona and Institut d'Investigació Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Clinical Reasoning: A Dizzy Architect
Adrian Scutelnic, Aikaterini Galimanis, Michael Horn, Lidia Sabater, Niklaus Meier
Neurology Mar 2022, 98 (13) 543-549; DOI: 10.1212/WNL.0000000000200019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
880

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

There is an increasing body of evidence describing an association between anti–Kelch-like protein 11 (KLHL11) encephalitis and various tumors such as seminoma. However, when the diagnosis of neoplasia is uncertain and the clinical syndrome resembles those caused by other etiologies, the possibility of anti-KLHL11 encephalitis may not be obvious during early clinical evaluations. We present the case of a 68-year-old man with clinical features of anti-KLHL11 encephalitis, in whom no clear signs of an active neoplasia could be found. However, a burnt-out germ cell tumor was suspected. This case highlights the importance of having a high clinical suspicion for anti-KLHL11 encephalitis in patients who exhibit symptoms and signs, even in the absence of an active tumor.

Section 1

A 68-year-old retired architect with an unremarkable medical and family history presented to his primary care provider with acute vertigo, nausea, and vomiting. There was no history of excessive alcohol consumption, illicit drug use, or exposure to toxins. He was a smoker (33py). A brain MRI showed nonspecific white matter disease (Figure 1A) but was otherwise normal. He was diagnosed with vestibular neuritis and was prescribed symptomatic treatment, which led to partial improvement.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Brain MRI Scans

(A) Initial brain MRI (FLAIR, coronal view) showing nonspecific white matter hyperintensities. (B) Initial brain MRI (T1-MPR after IV gadolinium, axial view) showing patchy gadolinium enhancement in the pons involving the right lateral pontomedullary junction and paramedian structures (arrows). (C) Brain MRI after 6 months (FLAIR, coronal view) showing progressive atrophy and white matter disease. (D) Brain MRI after 6 months (T1-MPR after IV gadolinium, axial view) without gadolinium enhancement.

Over the next 5 months, he complained of fluctuating vertigo and nausea, fatigue, a 13-kg weight loss, and depression with anxiety. There were no headaches, diplopia, dysphagia, dysarthria, muscle weakness, troubles with coordination or sensation, diarrhea, vomiting, joint pain, fever, night sweats, or skin/mucosal changes.

In the 4 weeks before admission, he had progressive diplopia and difficulty walking. On examination, the patient was fully oriented, afebrile, and in a poor general state of health. Spontaneous grade I horizontal left-beating nystagmus, catch-up saccades during the head-impulse test to the right, and saccadic slowing to the right with limited range of motion were observed. Smooth pursuit eye movements and vestibulo-ocular reflex (VOR) to the right were preserved. Strength and sensation to light touch were normal. Pallesthesia was 4–5/8 on both malleoli. Reflexes were 1+ on the right and 2+ on the left. Slight ataxia was present in all extremities along with a slight unsteadiness while standing. Romberg sign was negative. Straight-line walking was impossible.

Question for Consideration:

  1. What is the localization of the symptoms/signs?

GO TO SECTION 2

Section 2

Left-beating spontaneous nystagmus and pathologic head-impulse test to the right are typically signs of a right-sided peripheral vestibulopathy, yet the fluctuating vertigo and nausea for 6 months and ocular motor disturbances make this unlikely. A lesion of the lateral pontomedullary junction involving the vestibular nerve root entry zone and the vestibular nuclei can mimic a lesion of the vestibular nerve. The saccadic gaze palsy with slowing to the right indicates a lesion of the right paramedian pontine reticular formation (PPRF). Ataxia of all limbs, stance, and gait are compatible with a pan-cerebellar dysfunction. In sum, all signs can be explained by a CNS disorder involving the right paramedian caudal pons, right lateral pontomedullary junction, and the cerebellum. The combination of cerebellar and pontomedullary dysfunction is defined as rhombencephalopathy.

During the first days of hospitalization, the patient complained of progressive diplopia and gait disturbance. Clinical signs progressed: saccades to the right became increasingly slow until, 6 days after admission, volitional saccades to the right were impossible. Saccades to the left became slowed as well, as did vertical saccades. Convergence remained intact, as did reflexive (smooth pursuit, VOR) conjugated eye movements except for muscle weakness in the right lateral rectus. Upward gaze was limited, speech became scanning, and gait increasingly broad based with need for a walker-rollator. Reflexes on the left side became exaggerated. In addition, periocular myorhythmia and limb fasciculations appeared. Slight behavioral disinhibition, memory deficits, and a positive applause sign were noted.

Questions for Consideration:

  1. What structures are involved explaining the progressive ocular motor disturbance?

  2. What is the differential diagnosis?

  3. Which investigations would you perform?

GO TO SECTION 3

Section 3

The progressive ocular motor signs are due to increasing dysfunction of both PPRFs, mostly the caudal parts and more on the right, and the abducens nerve fascicle innervating the right lateral rectus muscle. Altogether, the clinical syndrome is that of a subacute-progressive rhombencephalopathy with additional frontotemporal (disinhibition and memory deficits) and peripheral nervous system (myorhythmia and fasciculations) symptoms/signs. The initial fluctuating symptoms followed by rapid progression over several weeks, widespread nervous system involvement, and normal MRI at symptom onset make an ischemic, toxic, neurodegenerative, genetic, or mechanical cause unlikely. Likely pathogenetic causes are autoimmune-inflammatory, infectious, or metabolic.

The clinical picture here fits well into that of inflammation (i.e., rhombencephalitis), be there external pathogens (i.e., infectious/parainfectious), neoplasia (neoplastic or paraneoplastic), or idiopathic causes (i.e., rheumatologic diseases). A paraneoplastic disorder seemed possible, for example, associated with Ma-2/Ta, Yo, Hu, GAD, or CRMP5/CV2 antibodies. The rather long course and lack of infectious symptoms before neurologic symptoms argued against a parainfectious pathogenesis, yet a GQ1b antibody–associated disorder seemed possible. CNS tuberculosis seemed unlikely due to lack of immunosuppression, night sweats, fever, or chronic cough. An infection with Tropheryma whipplei (Whipple disease) can lead to myorhythmia, psychiatric symptoms, and gaze disturbances, but intestinal symptoms and fever are typically present. Myocloni, fasciculations, and cerebellar and pyramidal symptoms also evoke prion disease, but there was no evidence of dementia. Neuro-Behçet syndrome was considered unlikely due to the lack of oral or genital ulcers, as was progressive multifocal leukoencephalopathy because there was no immunosuppression whatsoever. Of course, thiamine deficiency should always be considered (and treated!) in patients with neuro-ophthalmic disorders and ataxia. The initial brain MRI performed 6 months before hospitalization was reanalyzed, and a patchy Gadolinium enhancement of the pontomedullary junction was noted (Figure, B, arrows).

In conclusion, an autoimmune encephalitis seemed most likely. Considering the weight loss, which was ongoing during hospitalization culminating in 15 kg within 6 months, a paraneoplastic pathogenesis was probable. The results of the diagnostic tests are shown in the Table.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table

Investigations

Questions for Consideration:

  1. How do you interpret the results? What other tests would you order?

  2. Would you treat the patient? How?

GO TO SECTION 4

Section 4

Compared with the initial MRI 6 months earlier, the actual brain MRI showed generalized cortical-subcortical atrophy (Figure, C) without DWI abnormalities or gadolinium enhancement (Figure, D). The white matter lesions were slightly progressive. CSF was inflammatory without signs of infection: Protein content was increased (with normal cell count), and >5 unmatched oligoclonal IgG bands (OCBs) were present. The presence of OCBs suggests inflammation (e.g., autoimmune) within the CSF. An extensive search for onconeural and autoimmune encephalitis antibodies revealed no positive results. Parainfectious and systemic antibodies were negative. No tumor could be found, yet sonography of the left testis showed hypoechogenicity and a reduced vascularization. Alpha-fetoprotein (AFP) was slightly elevated. A left orchiectomy was performed. Histologic examination of the entire left testis revealed fibrotic testicular tissue with no evidence of neoplasia. After orchiectomy, AFP returned to normal.

IV methylprednisolone 1000 mg daily for 3 days was begun due to a high level of suspicion for an inflammatory autoimmune etiology. The steroid treatment brought no significant clinical improvement.

Questions for Consideration:

  1. Would you change the treatment?

  2. What investigations would you perform?

GO TO SECTION 5

Section 5

Because of the lack of clinical improvement and suspicion of an autoimmune inflammatory etiology, he received IV immunoglobulins (IVIGs) 0.4 g/kg daily for 5 days, followed by a long-term tapered regimen of oral prednisolone. A slight improvement in ocular motility and gait was observed. Body FDG-PET-CT showed no signs of neoplasia.

We interpreted the histologic testicular findings as a burnt-out germ cell tumor and had Kelch-like protein 11 (KLHL11) antibodies in serum and CSF analyzed, which turned out positive (titer in serum 1:160,000, in CSF 1:16,000). The diagnosis of a KLHL11 antibody–associated paraneoplastic encephalitis (predominantly rhombencephalitis) was made.

The patient was discharged to a rehabilitation clinic. Five months after discharge, he developed spontaneous skin hematomas. An acquired hemophilia was diagnosed, and therapy with cyclophosphamide, plasmapheresis, and IVIG was initiated, followed by long-term immunosuppression with rituximab. Prednisolone was tapered over 10 months. In the 1.5 years after diagnosis, gait and eye motility improved: the patient is now able to walk with bilateral walking aids without risk of falling. He gained 8 kg and reported significant improvement in mood. Unfortunately, cognition deteriorated significantly resulting in a mild dementia, so the patient moved to a nursing home.

Discussion

KLHL11 antibody–associated paraneoplastic encephalitis associated with (regressed) germ cell tumor was first described in 20191; KLHL11 antibodies appear to be one of the most common neurologic paraneoplastic antibodies with a prevalence of 1.4/100,000.1-3 KLHL11 is an intracellular protein playing a role in ubiquitination. Histopathologic studies of patients with seminoma and KLHL11 antibody encephalitis showed T-cell lymphocytic infiltrates within seminoma tissue, suggesting T-cell activation by an onconeuronal antigen.2

The most common neurologic syndrome in KLHL11 antibody encephalitis is rhombencephalitis alone or in combination with limbic encephalitis.1,2 However, limbic encephalitis may rarely occur alone. Half of affected patients have vertigo and a third hearing loss and tinnitus.2 Other clinical manifestations include seizures, neuropsychiatric symptoms such as anxiety and panic attacks, trigeminal neuropathy, fasciculations, and dementia. Patients without active neoplasia seem to have a worse prognosis.2 Whether hemophilia is associated with KLHL11 antibody encephalitis remains unclear.

The diagnostic challenge of this case resides in the absence of known autoimmune encephalitis antibodies and the presence of only subtle clues of testicular cancer, despite a comprehensive workup. Nevertheless, an inflammatory pathophysiology was suspected early. This case highlights the importance of thorough clinical reasoning in determining the neurologic syndrome, likely pathogenesis, and early treatment regimen, even in the absence of unequivocal pathogenetic evidence. In conclusion, subacute rhombencephalopathy with testicular fibrosis should prompt the search for anti-KLHL11 antibodies.

Study Funding

No targeted funding reported.

Disclosure

A. Scutelnic, A. Galimanis, and M. Horn report no disclosures relevant to the manuscript. L. Sabater reports no disclosures relevant to the manuscript. She received a grant from Instituto de Salud Carlos III cofunded by European Union, No PI18/00067. N. Meier reports no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

Acknowledgment

The authors thank Christine Egger, MD, Pathologie Länggasse, Bern, for the histopathological analysis.

Appendix Authors

Table

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • © 2022 American Academy of Neurology

References

  1. 1.↵
    1. Mandel-Brehm C,
    2. Dubey D,
    3. Kryzer TJ, et al.
    Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N Engl J Med. 2019;381(1):47-54.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Dubey D,
    2. Wilson MR,
    3. Clarkson B, et al.
    Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic Kelch-like protein-11 encephalitis. JAMA Neurol. 2020;77(11):1420-1429.
    OpenUrl
  3. 3.↵
    1. Maudes E,
    2. Landa J,
    3. Munos-Lopetegi A, et al.
    Clinical significance of Kelch-like protein 11 antibodies. Neurol Neuroimmunol Neuroinflamm. 2020;7(3):e666.
    OpenUrlAbstract/FREE Full Text

Disputes & Debates: Rapid online correspondence

  • Author Response: Clinical Reasoning: A Dizzy Architect
    • Niklaus Meier, MD, Department of Neurology, Thun Hospital, Thun, Switzerland
    Submitted May 19, 2022
  • Reader Response: Clinical Reasoning: A Dizzy Architect
    • Herminia Argente Escrig, Neurologist, Hospital Universitari i Politècnic La Fe
    Submitted May 13, 2022
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Section 1
    • Section 2
    • Section 3
    • Section 4
    • Section 5
    • Discussion
    • Study Funding
    • Disclosure
    • Acknowledgment
    • Appendix Authors
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • Resident & Fellow Rounds: March 2022

Alert Me

  • Alert me when eletters are published
Neurology: 99 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise